NCT04365790Active, not recruiting
Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma
Investigation of Gene Mutations or Changes in Protein Expression,as Biomarkers With Prognostic/Predictive Value, in Patients With Triple-negative and in Patients With HER2+ Breast Cancer Adenocarcinoma,Who Underwent Intensive Adjuvant Chemotherapy
Source: ClinicalTrials.gov · Last updated 14 Oct 2026
Brief summary (registry, in English)
The present study is a transnational study in patients with high risk recurrent breast cancer who receive adjuvant chemotherapy with epirubicin and cyclophosphamide followed by docetaxel or paclitaxel.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 500 (actual)
- First submitted
- 24 Apr 2020
- Start date
- 18 Apr 2013
- Primary completion date
- 13 Jul 2026
- Lead sponsor
- Hellenic Cooperative Oncology Group
- Diseases
- Triple-negative breast cancer
- NCT number
- NCT04365790
What you commit to
- Study type: Observational
- Participants enrolled: 500
- From 18 Apr 2013 to the primary completion date, 13 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- 18 years or older
- Αny menopausal status is allowed
- triple-negative breast cancer
- HER2+ breast adenocarcinoma
- tumor size \<= 5 cm
- presence of operable axillary lymph nodes or the presence of clinicopathological parameters indicating an intermediate or high risk of recurrence without the presence of infiltrated lymph nodes
- Performance status (PS) = 0 or 1
- adequate bone marrow function , heart, liver and kidney
- no other history of previous neoplasm or other serious illness
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| George Fountzilas Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.